"Regulators don't fear AI. They fear black boxes." - Vivek Adarsh, Co-Founder & CEO, Mithrl
In our #JPM26 panel with healthcare and life sciences innovators, we explored the intersection of AI and biology. The panel considered how to uphold vital principles such as safety, transparency, and evidence-based science while harnessing AI's potential.
Hear a snippet of this discussion theme and connect with us to work together and set the standard for transparent AI technology in Life Sciences, for pharma, biotech, and beyond.
#JPM2026 @flyingthor
We had a blast at @UCSF last week, discussing with researchers their work and the latest in agentic AI to accelerate discovery and delve deeper into transcriptomics, proteomics, and other research data.
It was great to share the tabletop space with fantastic companies and teams as well; what a welcoming community! @idtdna, @Elemental_io, @PackGeneBiotech, @MilliporeSigma, and more.
@GarredGarred #AIinLifeSciences #Proteomics #UCSF
#JPMHealthcareWeek just got a must-attend satellite event! 🎉
If you care about where discovery research, biotech, and AI are really heading, join us for happy hour and discussions:
The End of Slow Science: Inside Pharma’s AI-Accelerated Future
Wed, Jan 14 | 5–8 PM | 100 Montgomery St, Ste. 1200, San Francisco
Two panels, gourmet food, craft drinks, and some of the most forward-thinking leaders in the biopharma ecosystem, all in one room.
🎟️ Free (registration reviewed): https://t.co/iWfFN6LtMT
#LifeSciences #JPMHealthCare @idtdna@nanopore@plasmidsaurus@novonordisk@ExelixisInc@AstellasUS@Roche@dnanexus@freenome@DanaherCorp@SynBioBeta@flyingthor
🚀 What are the value-based outcomes of AI in discovery science? Find out in the latest @mendelspod episode featuring our very own CEO and Co-Founder, Vivek Adarsh, PhD.
Theral Timpson sits down with Vivek to explore how Mithrl’s AI platform is turning weeks of bioinformatics analysis into minutes, helping researchers:
✔️ Identify new biomarker candidates in minutes instead of weeks
✔️ Catch costly errors before they happen
✔️ Multiply opportunities for “happy accidents” that can lead to discovery
Vivek also shares the vision behind Mithrl: building a true partner for science that accelerates the journey from raw data to real discovery.
🎧 Listen here: https://t.co/Gyo0F9wppn
@flyingthor #Mendelspod #AIinScience #Bioinformatics #Pharma
💡 #AI is transforming #DrugDiscovery!
Join Vivek Adarsh, PhD (@flyingthor) & Mary Janatpour, PhD to see how #pharma & #biotech teams use AI to turn data into insights, speed target discovery & collaborate smarter.
📅 20 Nov | 12PM ET
🎟️ Register: https://t.co/2qCg36GoW3
Happening Now! A great lineup ft. Dr. Christian Marshall presenting on how @SickKidsNews has developed an integrated solution for Genome-Wide Sequencing using cloud computation! I am excited!
https://t.co/OFyTabWYwN
.@Illumina is hosting a free virtual event w/ experts talking about bringing #WGS into an acute-care setting. Dr. Kristen Wigby will present "The Utility of Whole Genome Sequencing in the NICU/PICU" on 9/27. Register: https://t.co/H9eBqY5LMu
#pediatrics#Genomics
The modern story of the Human Genome Project, told by @genome_gov — going from 1 human reference genome (2003) to 350 human references in a pangenome to better represent our diverse Homo sapiens species. Amazing 5 min public-science explainer video! https://t.co/vdnG1R4Ii2
The GenCC publication is now available in @GIMJournal! DiStefano et al. "The Gene Curation Coalition: A global effort to harmonize gene–disease evidence resources" https://t.co/FyTKwO43ta 1/6
By the end of 2022, according to the American Cancer Society, there will be an estimated 609,360 deaths caused by cancer in the United States. It’s important that we catch, diagnose and treat cancer as early as possible. https://t.co/lrlb43E0t2
"Despite evidence and major professional society recommendations, utilization and awareness of cardiogenomic testing remains low. CGTA will strive to inform healthcare providers about the current guidelines for the appropriate use of genetic testing in cardiology."
Good morning #ABRF2022 attendees! Grab a coffee and head over to Primrose A at 8:30am to hear Fiona Nohilly's Workshop Talk "Delivering New Capabilities on Illumina Sequencers”. https://t.co/O8v5RlUkKm
Honored for @Child_Neurology and @illumina to partner in such an innovative way… yielding diagnoses for families who had been waiting far Tom long. Another example of creative collaboration
Systemic racism needs to be considered when developing AI/ML tools. We need to pay attention to what we are measuring, and what we are not measuring. #ACMGMtg22